SEC Form SC 13G filed by Biomerica Inc.
$BMRA
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Health Care
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/5/2026 | $9.00 | Mkt Outperform | Citizens |
IRVINE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ:BMRA), a developer and manufacturer of diagnostic test systems and CDMO services provider, today announced it has entered into a Master Services Agreement (MSA) with a confidential life sciences company to develop proprietary in vitro diagnostic (IVD) assays. The engagement carries an initial contract development target fee of over $1.75 million, to be earned across multiple Statements of Work (SOWs) under the MSA. Biomerica was chosen following a competitive evaluation in which multiple CDMO organizations were assessed. The MSA establishes an initial three-year term with automatic one-year renewals. All developm
Veteran finance and operations leader brings more than 20 years of experience across public companies and high-growth organizations ConsumerDirect Inc., an industry leader in helping consumers manage their credit, money, and privacy, today announced the appointment of Gary Lu, CPA as Chief Financial Officer. Mr. Lu brings more than two decades of financial, accounting, and operational leadership across public companies, high-growth fintech, and Fortune 500 enterprises. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260519292056/en/Gary Lu, Chief Financial Officer In his role as Chief Financial Officer, Mr. Lu will oversee the
IRVINE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ:BMRA), a global biomedical technology company focused on innovative diagnostic-guided therapies, today announced that an abstract evaluating the real-world clinical effectiveness of its inFoods® IBS diagnostic-guided therapy has been accepted for poster presentation at Digestive Disease Week® (DDW) 2026, to be held May 2–5, 2026, at McCormick Place in Chicago, Illinois. DDW is the world's largest gathering of physicians, researchers, and industry professionals in gastroenterology, hepatology, and related GI disciplines. Acceptance of this poster reflects the growing interest within the gastroenterology community in
Citizens initiated coverage of Biomerica with a rating of Mkt Outperform and set a new price target of $9.00
4 - BIOMERICA INC (0000073290) (Issuer)
4 - BIOMERICA INC (0000073290) (Issuer)
4 - BIOMERICA INC (0000073290) (Issuer)
8-K - BIOMERICA INC (0000073290) (Filer)
10-Q - BIOMERICA INC (0000073290) (Filer)
S-8 - BIOMERICA INC (0000073290) (Filer)
Veteran finance and operations leader brings more than 20 years of experience across public companies and high-growth organizations ConsumerDirect Inc., an industry leader in helping consumers manage their credit, money, and privacy, today announced the appointment of Gary Lu, CPA as Chief Financial Officer. Mr. Lu brings more than two decades of financial, accounting, and operational leadership across public companies, high-growth fintech, and Fortune 500 enterprises. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260519292056/en/Gary Lu, Chief Financial Officer In his role as Chief Financial Officer, Mr. Lu will oversee the
Brings decades of leadership in laboratory testing, clinical diagnostics, payor strategy, and sales growth Extensive track record in commercializing advanced laboratory testing and insurer strategies IRVINE, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ:BMRA), a global provider of advanced diagnostic solutions, today announced the appointment of Gary Huff to its Board of Directors as an independent board member. Mr. Huff brings decades of leadership experience in the diagnostics and healthcare services industry, including serving as Chief Executive Officer of LabCorp Diagnostics, one of the world's largest clinical laboratories. Mr. Huff is a hands-on, inspirational,
Brings 20+ years of revenue growth leadership in laboratory testing, clinical diagnostics and global expansionLed successful organizational turnarounds and growth strategies at both Boston Heart Diagnostics and Genova DiagnosticsExtensive track record in commercializing advanced laboratory testing, driving growth and payer strategies IRVINE, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ:BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appointment of Scott Madel as Chief Commercial Officer. Scott brings more than two decades of cross-functional expertise in healthcare, diagnostics, commercialization, and pa
InFoods® IBS Data Receives American College of Gastroenterology Presidential Award (ACG) Following Presentation at Annual Scientific Meeting Trial Data Shows InFoods® IBS Treatment Diet Significantly Improved Several IBS Symptoms Including Abdominal Pain Intensity (API): In Some Cases Better Than Certain Currently Marketed Drugs Launch of InFoods® IBS Lab Developed Test Expected in Fiscal 3Q Amazon Now Fulfills Sales of Aware® Breast Self Exam and EZ Detect™ Colon Disease Tests IRVINE, Calif., Jan. 13, 2023 (GLOBE NEWSWIRE) -- IRVINE, CABiomerica, Inc. (NASDAQ:BMRA), (the "Company") a global provider of advanced medical products, today reported its second quarter fiscal 2023 fina
SC 13G/A - BIOMERICA INC (0000073290) (Subject)
SC 13G/A - BIOMERICA INC (0000073290) (Subject)
SC 13G - BIOMERICA INC (0000073290) (Subject)